<DOC>
	<DOC>NCT01414959</DOC>
	<brief_summary>The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.</brief_summary>
	<brief_title>Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients</brief_title>
	<detailed_description>Methods: microdialysis, blood sampling, bronchoalveolar lavage</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<criteria>endotracheal intubation; pneumonia or complicated abdominal infection or complicated urinary tract infection allergy to doripenem, hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>intensive care patient</keyword>
	<keyword>intubation</keyword>
	<keyword>(please change wording as you like!)</keyword>
</DOC>